Labiotech.eu

When AI isn’t enough: How physics is shaping the next wave of drug discovery

Discover what the next wave of AI-assisted drug discovery looks like and how it can help biotech - the AI and physics combo.
Business Wire

Elix Provides AI Drug Discovery Platform “Elix Discovery™” to Eisai

TOKYO--(BUSINESS WIRE)--Elix, Inc. (CEO: Shinya Yuki / Headquarters: Tokyo; hereinafter “Elix”) is pleased to announce that its AI drug discovery platform, Elix ...
News Medical

AI model can design optimal drug candidates without any prior molecular data

This process is costly, time-consuming, and has a low success rate. KAIST researchers have developed an AI model that, using only information about the target protein, can design optimal drug ...
News Medical

AlphaFold accelerates discovery of potential antipsychotic drugs by outperforming traditional methods

In a recent study published in the journal Science Advances, researchers in Sweden conducted virtual screens of over 16 million compounds using multiple receptor models developed by AlphaFold and ...
EurekAlert!

Artificial Intelligence-driven Strategies and Modern Innovations to Surpass Biopharmaceutic Limitations in Traditional Drug Development

Drug discovery is a high-risk, high-cost endeavor, with over 90% of candidates failing in clinical development. A significant proportion of these failures stem from unresolved biopharmaceutic ...
Morningstar

Genesis Molecular AI Unveils Pearl, a Field-Leading Foundation Model that Achieves Unprecedented Performance in Drug-Protein Structure Prediction

Genesis’ proprietary foundation model – Pearl – outperforms frontier models, including AlphaFold 3, on key benchmarks that predict utility in real-world drug discovery Pearl’s performance improved ...
C&EN

‘We are in the century of the protein’

An illustration of an algorithm predicting a protein structure, with digitized blocks on the left becoming ribbons on the right. An illustration of the RoseTTAFold software predicting a protein ...